South Florida patients see early promising results from new pancreatic cancer pill

When Russ Reed rang the bell marking the end of his cancer treatment in February 2025, he was declared free of disease after radiation, chemotherapy and surgery. Months later, the cancer returned.

Read more ‘Suspended in its entirety’: Miami-Dade sheriff to take down Flock cameras

Pancreatic cancer has long been one of medicine’s toughest fights — it’s notoriously hard to catch early and often spreads before doctors find it. Daraxonrasib — sold under the brand name Rasonque — a new Revolution Medicines drug approved by the FDA last week, nearly doubled median survival to 13.2 months from 6.7 months with chemotherapy alone, while causing fewer side effects. The once-daily pill costs roughly $39,800 for a one-month supply, and patients are pushing to get it.

Read more All-clear declared at Hollywood school that received threat, district says

Reed, a Port St. Lucie resident who travels to Broward for treatment, was approved to receive the treatment through an FDA Expanded Access Program that opened in early July, after standard treatments had stopped working for him.

Read more State asks judge to reconsider bail of ex-Palm Beach clerk in child sex abuse case

Read the full story at Sun-Sentinel.com.